Oxidative stress and advanced glycation in diabetic nephropathy

被引:52
作者
Coughlan, Melinda T. [1 ]
Mibus, Amy L. [1 ]
Forbes, Josephine M. [1 ]
机构
[1] Baker Heart Res Inst, JDRF Albert Einstein Ctr Diabet Complicat, Diabet & Metab Div, Melbourne, Vic 8008, Australia
来源
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES | 2008年 / 1126卷
关键词
advanced glycation end products (AGEs); diabetic nephropathy; reactive oxygen species (ROS); receptor for advanced glycation end products (RAGE); NADPH OXIDASE COMPONENTS; END-PRODUCTS; COMPLEX-I; NAD(P)H OXIDASE; RECEPTOR; RAGE; EXPRESSION; COMPLICATIONS; PATHOGENESIS; GLYCOXIDATION;
D O I
10.1196/annals.1433.018
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Nephropathy remains a significant cause of morbidity and mortality in the diabetic population and is the leading cause of end-stage renal failure in the Western World. As a result of the diabetic milieu, increased generation of reactive oxygen species (ROS) is thought to play a key role in the progression of diabetic nephropathy. Recent experimental studies have suggested that the receptor for advanced glycation end products (RAGE), which is central to the advanced glycation pathway, may mediate renal structural and functional damage via oxidative stress. This review focuses on how RAGE and subsequent ROS generation play a deleterious role in the diabetic kidney, promoting cross-talk among signaling pathways, ultimately leading to renal dysfunction.
引用
收藏
页码:190 / 193
页数:4
相关论文
共 43 条
[1]
Effects of NADPH oxidase inhibitor in diabetic nephropathy [J].
Asaba, K ;
Tojo, A ;
Onozato, ML ;
Goto, A ;
Quinn, MT ;
Fujita, T ;
Wilcox, CS .
KIDNEY INTERNATIONAL, 2005, 67 (05) :1890-1898
[2]
The neutrophil NADPH oxidase [J].
Babior, BM ;
Lambeth, JD ;
Nauseef, W .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) :342-344
[3]
Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[5]
Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[6]
Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes [J].
Cameron, NE ;
Cotter, MA .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 45 (2-3) :137-146
[7]
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: Synergy or redundancy? [J].
Coughlan, Melinda T. ;
Thallas-Bonke, Vicki ;
Pete, Josefa ;
Long, David M. ;
Gasser, Anna ;
Tong, David C. K. ;
Arnstein, Maryann ;
Thorpe, Suzanne R. ;
Cooper, Mark E. ;
Forbes, Josephine M. .
ENDOCRINOLOGY, 2007, 148 (02) :886-895
[8]
Coughlan MT, 2005, DIABETOLOGIA, V48, pA90
[9]
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice [J].
Flyvbjerg, A ;
Denner, L ;
Schrijvers, BF ;
Tilton, RG ;
Mogensen, TH ;
Paludan, SR ;
Rasch, R .
DIABETES, 2004, 53 (01) :166-172
[10]
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy [J].
Forbes, JM ;
Cooper, ME ;
Thallas, V ;
Burns, WC ;
Thomas, MC ;
Brammar, GC ;
Lee, F ;
Grant, SL ;
Burrell, LA ;
Jerums, G ;
Osicka, TM .
DIABETES, 2002, 51 (11) :3274-3282